(NASDAQ: NVCR) Novocure's forecast annual revenue growth rate of 8.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Novocure's revenue in 2024 is $509,338,000.On average, 5 Wall Street analysts forecast NVCR's revenue for 2024 to be $57,892,567,471, with the lowest NVCR revenue forecast at $56,674,915,149, and the highest NVCR revenue forecast at $58,569,397,961. On average, 5 Wall Street analysts forecast NVCR's revenue for 2025 to be $62,353,437,287, with the lowest NVCR revenue forecast at $61,262,797,776, and the highest NVCR revenue forecast at $63,924,069,561.
In 2026, NVCR is forecast to generate $70,439,633,964 in revenue, with the lowest revenue forecast at $64,759,398,330 and the highest revenue forecast at $76,808,480,365.